| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 63.710 | 37.830 | 38.987 | 44.549 | 91.626 | 56.609 | 48.332 | 70.733 | 15.765 | - |
| Total Income - EUR | 63.720 | 37.849 | 39.004 | 44.982 | 91.784 | 57.078 | 48.963 | 71.395 | 16.481 | - |
| Total Expenses - EUR | 46.407 | 27.674 | 28.514 | 39.236 | 72.741 | 44.191 | 41.263 | 63.286 | 14.800 | - |
| Gross Profit/Loss - EUR | 17.313 | 10.175 | 10.490 | 5.745 | 19.044 | 12.886 | 7.700 | 8.108 | 1.680 | - |
| Net Profit/Loss - EUR | 15.671 | 9.425 | 10.100 | 5.295 | 18.126 | 12.364 | 6.895 | 7.430 | 1.536 | - |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Df Group Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.077 | 5.799 | 1.596 | 813 | 2.335 | 1.669 | 1.025 | 418 | 16.562 | - |
| Current Assets | 28.829 | 32.141 | 52.281 | 59.714 | 66.308 | 76.080 | 84.274 | 88.859 | 87.057 | - |
| Inventories | 0 | 5.164 | 11.660 | 11.446 | 0 | 0 | 663 | 741 | 1.257 | - |
| Receivables | 15.853 | 18.515 | 18.661 | 21.821 | 34.656 | 29.726 | 31.567 | 29.955 | 80.950 | - |
| Cash | 12.975 | 8.462 | 21.961 | 26.447 | 31.652 | 46.354 | 52.044 | 58.164 | 4.850 | - |
| Shareholders Funds | 6.173 | 15.536 | 25.163 | 29.997 | 47.563 | 59.025 | 64.611 | 72.242 | 73.356 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 32.767 | 22.439 | 28.748 | 30.563 | 21.113 | 18.756 | 20.719 | 17.067 | 30.294 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Df Group Med Srl